The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors

Carlo G. Tocchetti, Giuseppina Gallucci, Carmela Coppola, Giovanna Piscopo, Clemente Cipresso, Carlo Maurea, Aldo Giudice, Rosario V. Iaffaioli, Claudio Arra, Nicola Maurea

Research output: Contribution to journalArticlepeer-review


Left ventricular dysfunction from anticancer drugs has emerged as a relevant problem in the clinical and scientific communities. Anthracycline toxicity has always been the most relevant, but with the increasing use of biological targeted therapies in treatment protocols, with an increasing number of cancer survivors, new toxicities have been increasing in more recent years. Cardiomyopathy after ErbB2 inhibitors has been intensively studied. Another important class of biological anticancer drugs are vascular endothelial growth factor (VEGF) inhibitors. VEGF signalling is crucial for vascular growth, but it also has a major impact on myocardial function. Also, it is important to note that such angiogenesis inhibitors are multitargeted in most cases, and can produce a broad spectrum of cardiovascular side effects. Here we review the mechanisms and pathophysiology of the most significant cardiotoxic effects of antiangiogenic drugs, and particular attention is drawn to LV dysfunction, discussing the assessment and management on the basis of the most recent cardio-oncological findings and heart failure guidelines. All rights reserved.

Original languageEnglish
Pages (from-to)482-489
Number of pages8
JournalEuropean Journal of Heart Failure
Issue number5
Publication statusPublished - May 2013


  • Anti-angiogenic drugs
  • Cardiovascular risk factors
  • Hypertension
  • Left ventricular dysfunction
  • Multitargeted tyrosine kinase inhibitors
  • VEGF

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The emerging issue of cardiac dysfunction induced by antineoplastic angiogenesis inhibitors'. Together they form a unique fingerprint.

Cite this